Three-Year Efficacy and Longitudinal Safety of Lisocabtagene Maraleucel (liso-cel) in Patients with Third-Line or Later (3L+) Follicular Lymphoma (FL) from TRANSCEND FL

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Sairah Ahmed, Alejandro Martín García-Sancho, Juan Luis Reguera Ortega, Guillaume Cartron, Aaron P. Rapoport, Koji Izutsu, Hervé Ghesquières, Hideki Goto, Jeremy S. Abramson, Peter Borchmann, Ulrich Jäger, Manali Kirtikumar Kamdar
+8 more Martin H. Dreyling, Merav Bar, Maria Strocchia, Martina Raggi, Luciana Bueno, Jessica Papuga, Silvia Colicino, Franck Morschhauser
DOI: 10.1016/j.jtct.2025.12.079
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S50–S51
Publication date
1 February 2026
Language
EN